VEGFR2 drugs for Hepatocellular Carcinoma

2 tracked VEGFR2 drugs in the Hepatocellular Carcinoma race. The class explanation lives on the VEGFR2 page; the full indication pipeline across every mechanism is on the Hepatocellular Carcinoma page.

1 approved / phase 41 Phase 3

Head-to-head evidence: Apatinib vs Ramucirumab

The roster

← all VEGFR2 drugs